MIM
WGS icon

MetLife Investment Management’s GeneDx Holdings WGS Stock Holding History

MetLife Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$695K Sell
10,820
-88
-0.8% -$8.02K ﹤0.01% 1594
2025
Q4 		$1.42M Hold
10,908
– – 0.01% 1239
2025
Q3 		$1.18M Sell
10,908
-381
-3% -$41.5K 0.01% 1348
2025
Q2 		$1.04M Buy
11,289
+3,650
+48% +$287K 0.01% 1291
2025
Q1 		$677K Sell
7,639
-111
-1% -$9.63K ﹤0.01% 1553
2024
Q4 		$596K Buy
7,750
+453
+6% +$31.6K ﹤0.01% 1708
2024
Q3 		$310K Buy
+7,297
New +$246K ﹤0.01% 2047
2022
Q3 		– Sell
-2,818
Closed -$117K – 2846
2022
Q2 		$117K Buy
+2,818
New +$191K ﹤0.01% 2649

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MetLife Investment Management's WGS Position: Q1 2026 in Review

MetLife Investment Management reduced its GeneDx Holdings (WGS) stake by 0.81% in Q1 2026, selling an estimated $8.02K and leaving 10,820 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

MetLife Investment Management first reported a position in WGS in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.42M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • MetLife Investment Management held 10,820 shares of GeneDx Holdings worth $695K as of Q1 2026.
  • MetLife Investment Management sold 88 GeneDx Holdings shares in Q1 2026, an estimated $8.02K.
  • GeneDx Holdings made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1594 holding.
  • MetLife Investment Management first reported a position in GeneDx Holdings in Q2 2022 and has held it in 8 quarters since.
  • MetLife Investment Management's GeneDx Holdings position peaked at $1.42M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.